comparemela.com

Page 3 - Dfran Lund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nasal vaccine yields promising results in mice

UAB is leading the way in research for an intranasal vaccine against COVID-19 which they say could be beneficial for many reasons.

COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial

COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial UAB and Altimmune collaborate on COVID-19 vaccine trial (Source: UAB) By WBRC Staff | February 19, 2021 at 3:24 PM CST - Updated February 19 at 3:24 PM BIRMINGHAM, Ala. (WBRC) - A big update in the COVID-19 vaccine testing at the University of Alabama at Birmingham. The Altimmune Inc. vaccine candidate that was tested at UAB in 2020 is expected to start patient enrollment for its Phase 1 clinical trial next week. Altimmune announced the United States Food and Drug Administration has cleared the company’s Investigational New Drug application for its Phase 1 clinical trial of AdCOVID.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.